He suggested that the ideal request for proposal (RfP) process ... "Mapping out strategies to overcome challenges in clinical research" was originally created and published by Clinical Trials ...

The European Union (EU) has released a clinical trial map as part of the Clinical Trials Information System (CTIS) to help ...

Bowen, A. and Nargundkar, S. (2025) Transformational Strategies to Improve the Clinical Trial and Drug Development Process.

They can also receive a customized map based on their preferences and ... family spent months working their way through the clinical trial process. By the time he was able to find another set ...

Splash Clinical and C2N Diagnostics have collaborated to enhance the recruitment process for clinical trials of Alzheimer's disease across the US and worldwide. This collaboration involves a ...

Throughout the MAPS/Lykos clinical trial process, the FDA gave every indication that it wanted to approve the treatment. During the panel discussion, Melissa Barone, a panelist and a psychologist ...

The development of new medications is a long, complex, and costly process. Productivity—how efficiently a drug developer creates value from their investment—is key to success, yet it often ...

You can decide to leave the trial at any time and for any reason. In addition, the informed consent process is ongoing. After you agree to a clinical trial, your medical team should continue to ...

One of the main challenges faced in the clinical trial process is the need to produce small batches of experimental medications before full approval is granted. This involves careful attention to ...

The latest solutions to be launched are: iSubmit, which automates the clinical trial document management process. It uses AI to improve compliance, reduce the burden on clinical project teams ...

The multi-center clinical trial has enrolled 258 healthy participants between the ages of 18 and 50 years, making this study the largest Phase I study conducted to date by Vaxxas with its HD-MAP ...

But patients of color, they say, don’t usually participate because of mistrust of the health care system, socioeconomic constraints, fear of the clinical trial process and a lack of information ...